Search Results

Stryker's TREVO 2 Data Presented at European Stroke Conference

May 24, 2012—Stryker (Kalamazoo, MI) announced that Raul G. Nogueira, MD, presented the results of the TREVO 2 clinical trial at the European Stroke Conference in Lisbon, Portugal. 

Trial Assesses 3D Stent Retriever as a Component of Penumbra's Mechanical Thrombectomy System

January 2, 2018—Raul G. Nogueira, MD, et al published results of a clinical trial evaluating the safety and efficacy of a novel three-dimensional (3D) stent retriever used in conjunction with an aspiration-based mechanical thrombectomy device (Penumbra System; Penumbra, Inc.) in terms of noninferiority to aspiration-based thrombectomy alone in acute ischemic stroke (AIS). The study is available online in the Journal of the American Medical Association (JAMA): Neurology.

DAWN Trial Results Published for Stryker's Trevo Retriever

November 13, 2017—Stryker announced that the results of the DAWN trial were published by Raul G. Nogueira, MD, et al online ahead of print in The New England Journal of Medicine. Dr. Nogueira and Tudor Jovin, MD, served as Coprincipal Investigators of the DAWN trial. In May, the company announced the presentation of the trial findings, which were presented at ESOC 2017, the European Stroke Organization Conference in Prague, the Czech Republic.

Perfuze’s Millipede88 Aspiration Catheter Cleared by FDA

March 17, 2026—Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) clearance for the Millipede88 aspiration catheter in mechanical neurovascular thrombectomy.

Perfuze’s Millipede88 Studied for Acute Ischemic Stroke in MARRS Trial

July 22, 2025—Perfuze, an Ireland-based developer of catheters for interventional stroke care, recently announced preliminary results from the United States pivotal trial of the Millipede 088 superbore aspiration catheter (Millipede88).